Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-03-30

FDA Approved: IOFLUPANE I 123 — Original Application (Curium US LLC)

View source ↗

Summary

The FDA approved IOFLUPANE I-123 (IOFLUPANE I-123) from Curium US LLC in an Original Application as a dopamine transporter imaging agent for SPECT to help evalu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IOFLUPANE I-123 (ioflupane I-123)

Snippet

ORIG AP for IOFLUPANE I 123 (IOFLUPANE I-123)